SCHEMBL3852801

SCHEMBL3852801

c1ccc(C(c2ccccc2)(c2ccccc2)n2cc(-c3ccc4ncnc(N5CCC(N6CCCCC6)CC5)c4c3)cn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.44
HRH1 P35367 1/20 0.44
CYP3A4 P08684 12/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 12/20 0.40
ALDH1A1 P00352 11/20 0.40
CLK4 Q9HAZ1 10/20 0.40
LMNA P02545 7/20 0.40
MAPK1 P28482 7/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
CYP2D6 P10635 4/20 0.40
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALOX15 P16050 2/20 0.40
CYP2C9 P11712 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
EGLN1 Q9GZT9 3/20 0.39
CYP2C19 P33261 9/20 0.39
TSHR P16473 7/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846539 0.86 CYP3A4 (0.44) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3845891 0.84 ACHE (0.47) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3846795 0.83 CYP1A2 (0.59) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3847535 0.82 CYP3A4 (0.43) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3845834 0.80 CYP3A4 (0.47) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3847438 0.80 SLC2A1 (0.53) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL5852369 0.79 CYP1A2 (0.43) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3847121 0.79 MAPT (0.50) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3845844 0.79 PHGDH (0.47) CYP3A4HPGDCYP1A2ALDH1A1CLK4
SCHEMBL3852021 0.78 CYP3A4 (0.43) CYP3A4HPGDCYP1A2ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed